P
Pankaj Dwivedi
Researcher at University of Science and Technology of China
Publications - 46
Citations - 1138
Pankaj Dwivedi is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Drug delivery & In vivo. The author has an hindex of 18, co-authored 46 publications receiving 878 citations. Previous affiliations of Pankaj Dwivedi include Council of Scientific and Industrial Research & University of Health Science.
Papers
More filters
Journal ArticleDOI
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
Ashwni Verma,Shweta Sharma,Pramod K. Gupta,Awadhesh Singh,B. Venkatesh Teja,Pankaj Dwivedi,Girish Gupta,Ritu Trivedi,Prabhat Ranjan Mishra +8 more
TL;DR: The study highlighted the role of VitB12 as a pH sensitive and targeting ligand which significantly participated in enhancing insulin oral bioavailability and multiple pathways to improve the overall bioavailability of insulin including paracellular transport and receptor mediated endocytosis.
Journal ArticleDOI
Pharmacokinetics study of arteether loaded solid lipid nanoparticles: An improved oral bioavailability in rats
Pankaj Dwivedi,Renuka Khatik,Kiran Khandelwal,Isha Taneja,Kanumuri Siva Rama Raju,Wahajuddin,Sarvesh Paliwal,Anil Kumar Dwivedi,Prabhat Ranjan Mishra +8 more
TL;DR: From the results, it can be concluded that ART-SLN offers a new approach to improve the oral bioavailability of ART and may help to protect the acid degradation of ART in stomach.
Journal ArticleDOI
Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
Monika Sharma,Ritu Malik,Ashwni Verma,Pankaj Dwivedi,Gabbar Singh Banoth,Nagendra Pandey,Jayant Sarkar,Prabhat Ranjan Mishra,Anil Kumar Dwivedi +8 more
TL;DR: These studies provide evidences that MTX-FA-GGNP holds promise to address colorectal cancer over-expressing folate receptors, and enjoys dual advantage of having propensity to release the drug in the colon and in the conditions of coloreCTal carcinoma.
Journal ArticleDOI
Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis
Shaswat Kansal,Rati Tandon,Pankaj Dwivedi,Pragya Misra,Priya Ranjan Prasad Verma,Anuradha Dube,Prabhat Ranjan Mishra +6 more
TL;DR: It is concluded that the PS targeting moiety can provide a new insight for efficient drug delivery to specialized macrophages and thus may be developed for effective use in macrophage-specific delivery systems, especially for leishmaniasis.
Journal ArticleDOI
Self Assembled Ionically Sodium Alginate Cross-Linked Amphotericin B Encapsulated Glycol Chitosan Stearate Nanoparticles: Applicability in Better Chemotherapy and Non-Toxic Delivery in Visceral Leishmaniasis
Pramod K. Gupta,Anil K. Jaiswal,Shalini Asthana,Ashwni Verma,Vivek Kumar,Prashant Shukla,Pankaj Dwivedi,Anuradha Dube,Prabhat Ranjan Mishra +8 more
TL;DR: The molecular organization, toxicity studies, desired localization and biodistribution of cost effective AmB-SA-GCS-NP was found to be highly effective and can be proved as practical delivery platform for better management of leishmaniasis.